+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
JLHL

Jupiter Life Line Hospitals Share Price

₹320.20 +0.95 (0.3%)
35.91% Gain from 52W Low

07 Aug, 2026 3:53 PM (IST)

Jupiter Life Line Hospitals live price: ₹320.20. It opened at ₹321 vs previous close ₹319; intraday high/low: ₹325/₹317. The 50 & 200 DMA stand at ₹297.50/₹279.30.

Jupiter Life Line Hospitals Performance

  • Today's Low
  • ₹317
  • Today's High
  • ₹325
  • 52 Week Low
  • ₹236
  • 52 Week High
  • ₹340
  • Open Price₹321
  • Previous Close₹319
  • Volume267,160
  • 50 DMA₹297.50
  • 100 DMA₹284.20
  • 200 DMA₹279.30

Jupiter Life Line Hospitals Chart

Investment Returns

  • Over 1 Month + 10.91%
  • Over 3 Month + 28.16%
  • Over 6 Month + 27.9%
  • Over 1 Year + 15.09%

Smart Investing Starts Here Start SIP with Jupiter Life Line Hospitals for Steady Growth!

Invest Now

Jupiter Life Line Hospitals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 56
  • PEG Ratio
  • -21.1
  • Market Cap Cr
  • 10,497
  • P/B Ratio
  • 6.8
  • Average True Range
  • 11
  • EPS
  • 5.7
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 9.4
  • RSI
  • 61.54
  • MFI
  • 65.69

Latest Stock News Updates

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Q1 FY27 Earnings Conference Call - Transcript

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation of Newspaper Publication for Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30,2026.

Jupiter Life Line Hospitals Ltd - 543980 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio Link of Analyst/ Investor Conference Call for Q1 FY27

Jupiter Life Line Hospitals Financials

Jupiter Life Line Hospitals Technicals

EMA & SMA

Current Price
₹320.20
+ 0.95 (0.3%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹315.30
  • 50 Day
  • ₹297.50
  • 100 Day
  • ₹284.20
  • 200 Day
  • ₹279.30

Resistance and Support

320.43 Pivot Speed
  • R3 332.20
  • R2 328.40
  • R1 324.30
  • S1 316.30
  • S2 312.50
  • S3 308.40

Jupiter Life Line Hospitals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-31 Quarterly Results
2026-05-15 Quarterly Results, Int. Dividend & Stock Split
2026-01-30 Quarterly Results
2025-11-07 Quarterly Results
2025-08-01 Quarterly Results
Date Purpose Remarks
2026-05-22 INTERIM Rs.1.00 per share(10%)Interim Dividend
2025-07-04 FINAL Rs.1.00 per share(10%)Final Dividend
2024-08-02 FINAL Rs.1.00 per share(10%)Final Dividend
View Jupiter Life Line Hospitals Dividend History Arrow
Date Purpose Remarks
2026-07-24 Split Stock split from Rs. 10/- to Rs. 2/-.

Jupiter Life Line Hospitals Shareholding Pattern

40.91%
33.2%
10.89%
9.37%
5.62%

About Jupiter Life Line Hospitals

Jupiter Life Line Hospitals is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and western India. View More
  • NSE Symbol
  • JLHL
  • BSE Symbol
  • 543980
  • Executive Director,Joint Managing Director,Chief Executive Officer
  • ANKIT AJAY THAKKER
  • ISIN
  • INE682M01020

Similar Stocks to Jupiter Life Line Hospitals

Jupiter Life Line Hospitals FAQs

Jupiter Life Line Hospitals share price is ₹320 As on 09 August, 2026 | 07:37

The Market Cap of Jupiter Life Line Hospitals is ₹10497.1 Cr As on 09 August, 2026 | 07:37

The P/E ratio of Jupiter Life Line Hospitals is 56 As on 09 August, 2026 | 07:37

The PB ratio of Jupiter Life Line Hospitals is 6.8 As on 09 August, 2026 | 07:37

The 52 week High & Low of Jupiter Life Line Hospitals is ₹340/₹235.6 respectively As on 09 August, 2026 | 07:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23